« Previous
Next »
Reproductive BioMedicine Online
Volume 19, Issue 4
, Pages
486-492
, October 2009
GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study
To access this article, please choose from the options below
☆
Dr Marco Melo is a gynaecologist, specializing in reproductive medicine. He obtained his MD and PhD degrees at the Federal University of Minas Gerais, Brazil. During the last five years, he has been working as a specialist in reproduction at the Instituto Valenciano de Infertilidad, a university-affiliated infertility clinic of Valencia, Spain. Moreover, since 2005, he has been involved in teaching the Masters degree in Reproductive Biotechnology from the Instituto Universitario IVI, Valencia University. He is author and co-author of several publications and book chapters. His research interests include reproductive endocrinology, embryo implantation and ovarian induction protocols.Dr Melo
PII: S1472-6483(09)00010-8
doi: 10.1016/j.rbmo.2009.06.001
© 2009 Reproductive Healthcare Ltd, Duck End Farm, Dry Drayton, Cambridge CB23 8DB, UK. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Reproductive BioMedicine Online
Volume 19, Issue 4
, Pages
486-492
, October 2009
